MED1 and pulmonary hypertension: MED1 is a well-known hypoxia-sensitive transcriptional coactivator and has been extensively studied in various diseases, such as atherosclerosis, pulmonary hypertension, breast cancer, etc. It binds to transcription factors and RNA polymerase II to exert biological effects [10–12].